PATENT CLAIM ANALYSIS

Application Number: 15882543
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "307000"]

Abstract:
Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention.

Claim (Index 15):
An isolated compound of Formula I:

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.41463
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14556715', '15144892', '12909241', '13713238', '12386361']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7957450250434893
- 35 USC 102 Novelty (BERT): 0.5390221577035597
- Combined Prediction Score: 0.7700727383094963
- Mean Citation Score: 350.825666
- Max Citation Score: 353.98785
- Similarity Product: 189.0260654526651

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test